Salesforce shares rise on $1.6 billion U.S. Veterans Affairs AI contract

Author: Wajeeh Khan Source: Barchart.com

Salesforce (CRM) shares are rallying on July 24 after management announced a new $1.6 billion contract with the U.S. Department of Veterans Affairs (VA).

Under this agreement, the VA will deploy Salesforce's artificial intelligence (AI) agents, data platforms, and collaboration tools to streamline healthcare delivery and improve appointment scheduling efficiency for veterans.

Despite today's surge, Salesforce stock remains down approximately 38% year-to-date.

Salesforce to Modernize Veteran Care

The Agentic Enterprise License Agreement (AELA) includes a one-year base period and two annual renewal options.

In its press release, Salesforce stated that the VA will implement its Missionforce ecosystem, integrating the following solutions:

• Agentforce Public Sector and Health solutions
• Slack
• MuleSoft
• Data 360
• Tableau

Embedding autonomous AI agents directly into live workflows will automate benefits verification, streamline patient triage, and reduce appointment scheduling times from 28 days to minutes.

This high-profile deployment highlights immediate real-world demand for Salesforce's next-generation AI platforms within large-scale healthcare and government operations.

Notably, CRM shares have historically gained an average of 4.81% in August — a seasonal pattern that may enhance near-term appeal for investors.

What the VA Deal Means for CRM Shares

For investors, this $1.6 billion VA contract represents a significant vote of confidence in Salesforce's AI monetization capabilities amid a challenging macroeconomic environment for software stocks.

The agreement adds to a growing list of federal contracts for the company's Missionforce unit, including:

• A $5.6 billion U.S. Army deal
• A $72 million Air Force agreement

By securing long-term enterprise commitments from government agencies, Salesforce is building a highly predictable multi-year revenue stream. These deals help alleviate investor concerns about enterprise AI adoption, demonstrating that CRM's agentic platform is actively replacing legacy administrative processes with scalable, high-margin software solutions.

Wall Street Remains Bullish on Salesforce Stock

Even prior to the VA announcement, Wall Street analysts held a constructive outlook on Salesforce for the remainder of 2026.

The consensus rating on CRM stock remains at "Moderate Buy," with a mean price target of $249 — suggesting potential upside of more than 60% from current levels.

On the date of publication, Wajeeh Khan did not hold (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is for informational purposes only. This article was originally published on Barchart.com.